Literature DB >> 15240993

Antiallergic activity of hesperidin is activated by intestinal microflora.

Neung-Kee Lee1, Seung-Hoon Choi, Sung-Hwan Park, Eun-Kyung Park, Dong-Hyun Kim.   

Abstract

When hesperidin isolated from pericarpium of Citrus unshiu (family Rutaceae) was incubated with human intestinal microflora, its main metabolite was hesperetin, which was a main metabolite in urine of orally hesperidin-administered rats. The antiallergic activity of hesperidin and its metabolite hesperetin were investigated. Hesperidin did not inhibit the histamine release from RBL-2H3 cells induced by IgE. However, its metabolite hesperetin potently inhibited the histamine release from RBL-2H3 cells induced by IgE and the PCA reaction. The inhibitory activity of hesperetin was found to be comparable with azelastine, a commercially available antiallergic drug, and to potently inhibit prostaglandin E2 production in lipopolysaccharide-stimulated RAW 264.7 cells. Hesperetin weakly inhibits cyclooxygenase 2 enzyme activities. These results suggest that hesperidin may be a prodrug, which is metabolized to hesperetin by intestinal bacteria. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240993     DOI: 10.1159/000078083

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  18 in total

1.  Quantitative estimation of hesperidin by HPTLC in different varieties of citrus peels.

Authors:  Prawez Alam; Aftab Alam; Md Khalid Anwer; Saleh I Alqasoumi
Journal:  Asian Pac J Trop Biomed       Date:  2014-04

2.  Radioprotective effect of hesperetin against γ-irradiation-induced DNA damage and immune dysfunction in murine splenocytes.

Authors:  Jung Ae Kang; Seon Hye Yoon; Jong Kook Rho; Beom-Su Jang; Dae Seong Choi; Dong-Eun Lee; Eui-Baek Byun; Jongho Jeon; Sang Hyun Park
Journal:  Food Sci Biotechnol       Date:  2016-03-31       Impact factor: 2.391

3.  Hesperedin promotes MyoD-induced myogenic differentiation in vitro and in vivo.

Authors:  Hana Jeong; Joo Yeon Lee; Eun Jung Jang; Eun Hye Lee; Myung Ae Bae; Jeong-Ho Hong; Eun Sook Hwang
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 4.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

5.  In vivo pharmacokinetics of hesperidin are affected by treatment with glucosidase-like BglA protein isolated from yeasts.

Authors:  Yong-Mei Li; Xiao-Mian Li; Guang-Ming Li; Wen-Cai Du; Jing Zhang; Wei-Xia Li; Jianshe Xu; Ming Hu; Ze Zhu
Journal:  J Agric Food Chem       Date:  2008-06-21       Impact factor: 5.279

Review 6.  The influence of gut microbiota on drug metabolism and toxicity.

Authors:  Houkai Li; Jiaojiao He; Wei Jia
Journal:  Expert Opin Drug Metab Toxicol       Date:  2015-12-10       Impact factor: 4.481

7.  Extract from peel of Citrus natsudaidai alleviates experimental chronic allergic dermatitis in mice.

Authors:  Noriyuki Nakayama; Katsunori Yamaura; Maki Shimada; Koichi Ueno
Journal:  Pharmacognosy Res       Date:  2011-07

Review 8.  Gut Microbiota: A Novel Regulator of Cardiovascular Disease and Key Factor in the Therapeutic Effects of Flavonoids.

Authors:  Qinyu Li; Bing Gao; Bateer Siqin; Qian He; Ru Zhang; Xiangxi Meng; Naiheng Zhang; Na Zhang; Minhui Li
Journal:  Front Pharmacol       Date:  2021-06-16       Impact factor: 5.810

Review 9.  Herbal Medicine, Gut Microbiota, and COVID-19.

Authors:  Ziqi Chen; Yiwen Lv; Huachong Xu; Li Deng
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.988

10.  Protective effects of natsumikan (Citrus natsudaidai) extract on acetaminophen-induced lethal hepatotoxicity in mice.

Authors:  Katsunori Yamaura; Noriyuki Nakayama; Maki Shimada; Koichi Ueno
Journal:  Pharmacognosy Res       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.